New Key Statistics Module, Z-Score and F-Score
SZSE:002082 Key Ratios
Market Cap ¥ M | 3,576.58 |
Enterprise Value ¥ M | 4,412.22 |
P/E(ttm) | 35.18 |
PE Ratio without NRI | 33.37 |
Forward PE Ratio | -- |
Price/Book | 1.35 |
Price/Sales | 2.31 |
Price/Free Cash Flow | 36.16 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.46 |
Revenue (TTM) ¥ M | 1,598.00 |
EPS (TTM) ¥ | 0.17 |
Beneish M-Score | -2.4 |
10-y EBITDA Growth Rate % | -5.80 |
5-y EBITDA Growth Rate % | -25.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 43.06 |
EV-to-EBITDA | 43.06 |
PEG | -- |
Shares Outstanding M | 616.69 |
Net Margin (%) | 6.37 |
Operating Margin % | 8.54 |
Pre-tax Margin (%) | 5.27 |
Quick Ratio | 1.12 |
Current Ratio | 1.35 |
ROA % (ttm) | 2.35 |
ROE % (ttm) | 3.83 |
ROIC % (ttm) | 3.05 |
Dividend Yield % | 1.34 |
Altman Z-Score | 2.49 |
SZSE:002082 Number of Guru Trades
SZSE:002082 Volume of Guru Trades
Gurus Latest Trades with SZSE:002082
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002082 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Wanbangde Pharmaceutical Holding Group Co Ltd Insider Transactions
No Available Data